Neuropeptidergic control of sleep and wakefulness

Annual Review of Neuroscience

Volumn 37, Issue , 2014, Pages 503-531

  Richter, Constance ^a   Woods, Ian G ^b   Schier, Alexander F ^a  

^a HARVARD UNIVERSITY   (United States)

^b ITHACA COLLEGE   (United States)

Author keywords

Feeding; Hypocretin; Local sleep; MCH; NREM; REM; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLECYSTOKININ; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CORTICOTROPIN RELEASING FACTOR; CORTISTATIN; DYNORPHIN; EPIDERMAL GROWTH FACTOR; GALANIN; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 1BETA; LEPTIN; MELANIN CONCENTRATING HORMONE; NEUROPEPTIDE; NEUROPEPTIDE Y; OREXIN; PROLACTIN; SOMATOSTATIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR;

AROUSAL; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN REGION; CIRCADIAN RHYTHM; EMOTION; HOMEOSTASIS; HORMONE ACTION; HUMAN; NONHUMAN; NONREM SLEEP; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REM SLEEP; REVIEW; SIGNAL TRANSDUCTION; SLEEP; SLEEP WAKING CYCLE; STRESS; WAKEFULNESS; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BRAIN; ENERGY METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; BRAIN; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MODELS, NEUROLOGICAL; NEUROPEPTIDES; SLEEP; STRESS, PHYSIOLOGICAL; WAKEFULNESS;

EID: 84904635124     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-062111-150447     Document Type: Review

References (181)

1. Adamantidis A, de Lecea L. 2009. The hypocretins as sensors for metabolism and arousal. J. Physiol. 587:33-40
2. Adamantidis A, SalvertD,Goutagny R, Lakaye B, GervasoniD, et al. 2008. Sleep architecture of themelaninconcentrating hormone receptor 1-knockout mice. Eur. J. Neurosci. 27:1793-800
3. Ahnaou A, Basille M, Gonzalez B, Vaudry H, Hamon M, et al. 1999. Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat. Eur. J. Neurosci. 11:4051-58
4. Ahnaou A, Yon L, Arluison M, Vaudry H, Hannibal J, et al. 2006. Immunocytochemical distribution of VIP and PACAP in the rat brain stem: implications for REM sleep physiology. Ann. N. Y. Acad. Sci. 1070:135-42
5. Allada R, Siegel JM. 2008. Unearthing the phylogenetic roots of sleep. Curr. Biol. 18:R670-79
6. Anaclet C, Lin JS, Vetrivelan R, Krenzer M, Vong L, et al. 2012. Identification and characterization of a sleep-active cell group in the rostral medullary brainstem. J. Neurosci. 32:17970-76
7. Antin J,Gibbs J, Holt J, Young RC, SmithGP. 1975. Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J. Comp. Physiol. Psychol. 89:784-90
8. Bachmann V, Klein C, Bodenmann S, Schafer N, Berger W, et al. 2012. The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep 35:335-44
9. Bargmann CI. 2012. Beyond the connectome: how neuromodulators shape neural circuits. Bioessays 34:458-65
10. Benedetto L, Rodriguez-Servetti Z, Lagos P, DAlmeida V, Monti JM, Torterolo P. 2013. Microinjection of melanin concentrating hormone into the lateral preoptic area promotes non-REM sleep in the rat. Peptides 39:11-15
11. Borbely AA. 1977. Sleep in the rat during food deprivation and subsequent restitution of food. Brain Res. 124:457-71
12. Broberger C. 1999. Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Res. 848:101-13
13. Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW. 2012. Control of sleep and wakefulness. Physiol. Rev. 92:1087-187
14. Burbach JPH. 2011. What are neuropeptides? In Neuropeptides: Methods and Protocols, ed. AMerighi, pp. 1-36. New York: Springer Sci.-Bus. Media
15. Burgess CR, Oishi Y, Mochizuki T, Peever JH, Scammell TE. 2013. Amygdala lesions reduce cataplexy in orexin knock-out mice. J. Neurosci. 33:9734-42
16. Campbell SS, Tobler I. 1984. Animal sleep: a review of sleep duration across phylogeny. Neurosci. Biobehav. Rev. 8:269-300
17. Cape EG, Manns ID, Alonso A, Beaudet A, Jones BE. 2000. Neurotensin-induced bursting of cholinergic basal forebrain neurons promotes gamma and theta cortical activity together with waking and paradoxical sleep. J. Neurosci. 20:8452-61
18. Carroll SB. 2008. Evo-devo and an expanding evolutionary synthesis: a genetic theory of morphological evolution. Cell 134:25-36
19. Carter ME, de Lecea L, Adamantidis A. 2013. Functional wiring of hypocretin and LC-NE neurons: implications for arousal. Front. Behav. Neurosci. 7:43
20. Chaki S, Kawashima N, Suzuki Y, Shimazaki T, Okuyama S. 2003. Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents. Eur. J. Pharmacol. 464:49-54
21. Chastrette N, Cespuglio R, Jouvet M. 1990. Proopiomelanocortin (POMC)-derived peptides and sleep in the rat. Part 1-Hypnogenic properties of ACTH derivatives. Neuropeptides 15:61-74
22. Chee MJ, Pissios P, Maratos-Flier E. 2013. Neurochemical characterization of neurons expressing melaninconcentrating hormone receptor 1 in the mouse hypothalamus. J. Comp. Neurol. 521:2208-34
23. Chiu CN, Prober DA. 2013. Regulation of zebrafish sleep and arousal states: current and prospective approaches. Front. Neural Circuits 7:58
24. Cho JY, Sternberg PW. 2014. Multilevel modulation of a sensory motor circuit during C. elegans sleep and arousal. Cell 156:249-60
25. Chou TC, Lee CE, Lu J, Elmquist JK, Hara J, et al. 2001. Orexin (hypocretin) neurons contain dynorphin. J. Neurosci. 21:RC168
26. Chou TC, Scammell TE,Gooley JJ, Gaus SE, Saper CB, Lu J. 2003. Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms. J. Neurosci. 23:10691-702
27. Clow A, Hucklebridge F, Stalder T, Evans P, Thorn L. 2010. The cortisol awakening response: more than a measure of HPA axis function. Neurosci. Biobehav. Rev. 35:97-103
28. Colten HR, Altevogt BM. 2006. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington, DC: Natl. Acad. Press
29. Coltro Campi C, Clarke GD. 1995. Effects of highly selective ?-opioid agonists on EEG power spectra and behavioural correlates in conscious rats. Pharmacol. Biochem. Behav. 51:611-16
30. ColwellCS. 2011. Linking neural activity and molecular oscillations in the SCN. Nat. Rev. Neurosci. 12:553-69
31. Crocker A, Sehgal A. 2010. Genetic analysis of sleep. Genes Dev. 24:1220-35
32. Dalal J, Roh JH, Maloney SE, Akuffo A, Shah S, et al. 2013. Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. Genes Dev. 27:565-78
33. de Lecea L. 2008. Cortistatin-functions in the central nervous system. Mol. Cell Endocrinol. 286:88-95
34. Devine DP, Taylor L, Reinscheid RK, Monsma FJJ, Civelli O, Akil H. 1996. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem. Res. 21:1387-96
35. DyzmaM, Boudjeltia KZ, Faraut B, Kerkhofs M. 2010. Neuropeptide Y and sleep. Sleep Med. Rev. 14:161-65
36. Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, et al. 2001. Characterization of CART neurons in the rat and human hypothalamus. J. Comp. Neurol. 432:1-19
37. Elmquist JK, BjrbaekC,Ahima RS, Flier JS, SaperCB. 1998. Distributions of leptin receptormRNAisoforms in the rat brain. J. Comp. Neurol. 395:535-47
38. Erickson JC, Clegg KE, Palmiter RD. 1996. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-21
39. Eriksson KS, Sergeeva OA, Selbach O, Haas HL. 2004. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons. Eur. J. Neurosci. 19:1278-84
40. Espana RA, Scammell TE. 2011. Sleep neurobiology from a clinical perspective. Sleep 34:845-58
41. Esposito M, Pellinen J, Kapas L, Szentirmai E . 2012. Impaired wake-promoting mechanisms in ghrelin receptor-deficient mice. Eur. J. Neurosci. 35:233-43
42. Feng P, Liu X, Vurbic D, Fan H, Wang S. 2007. Neonatal REM sleep is regulated by corticotropin releasing factor. Behav. Brain Res. 182:95-102
43. Fitzpatrick K, Winrow CJ, Gotter AL, Millstein J, Arbuzova J, et al. 2012. Altered sleep and affect in the neurotensin receptor 1 knockout mouse. Sleep 35:949-56
44. Flavell SW, Pokala N, Macosko EZ, Albrecht DR, Larsch J, Bargmann CI. 2013. Serotonin and the neuropeptide PDF initiate and extend opposing behavioral states in C. elegans. Cell 154:1023-35
45. Friedman LF, Zeitzer JM, Lin L, Hoff D, Mignot E, et al. 2007. In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1. Neurology 68:793-94
46. Fu LY, Acuna-Goycolea C, van den Pol AN. 2004. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 24:8741-51
47. Fuller PM, Sherman D, Pedersen NP, Saper CB, Lu J. 2011. Reassessment of the structural basis of the ascending arousal system. J. Comp. Neurol. 519:933-56
48. Furness JB, Hunne B, Matsuda N, Yin L, Russo D, et al. 2011. Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience 193:1-9
49. Furutani N, Hondo M, Kageyama H, Tsujino N, Mieda M, et al. 2013. Neurotensin co-expressed in orexinproducing neurons in the lateral hypothalamus plays an important role in regulation of sleep/wakefulness states. PLoS ONE 8:e62391
50. Gan EH, Quinton R. 2010. Physiological significance of the rhythmic secretion of hypothalamic and pituitary hormones. Prog. Brain Res. 181:111-26
51. Gao X-B,Horvath T. 2014. Function and dysfunction of hypocretin/orexin: an energetics point of view. Annu. Rev. Neurosci. 37:101-16
52. Garcia-Garcia F, Acosta-Pena E, Venebra-Munoz A, Murillo-Rodriguez E. 2009. Sleep-inducing factors. CNS Neurol. Disord. Drug Targets 8:235-44
53. Garcia-Garcia F, Juarez-Aguilar E, Santiago-Garcia J, Cardinali DP. 2014. Ghrelin and its interactions with growth hormone, leptin and orexins: implications for the sleep-wake cycle and metabolism. Sleep Med. Rev. 18:89-97
54. Gaus SE, Strecker RE, Tate BA, Parker RA, Saper CB. 2002. Ventrolateral preoptic nucleus contains sleepactive, galaninergic neurons in multiple mammalian species. Neuroscience 115:285-94
55. Gilbert J,Davis FC. 2009. Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters. Behav. Brain Res. 198:440-48
56. Greco MA, Fuller PM, Jhou TC, Martin-Schild S, Zadina JE, et al. 2008. Opioidergic projections to sleepactive neurons in the ventrolateral preoptic nucleus. Brain Res. 1245:96-107
57. HallbergM,Nyberg F. 2012. Growth hormone receptors in the brain and their potential as therapeutic targets in central nervous system disorders. Open Endocrinol. J. 6:27-33
58. Hanriot L, Camargo N, Courau AC, Leger L, Luppi PH, Peyron C. 2007. Characterization of the melaninconcentrating hormone neurons activated during paradoxical sleep hypersomnia in rats. J. Comp. Neurol. 505:147-57
59. Harris KD, Thiele A. 2011. Cortical state and attention. Nat. Rev. Neurosci. 12:509-23
60. Harvey J. 2007. Leptin: a diverse regulator of neuronal function. J. Neurochem. 100:307-13
61. HashimotoH, ShintaniN, Tanaka K,MoriW,HiroseM, et al. 2001. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc. Natl. Acad. Sci. USA 98:13355-60
62. Hashimoto H, Shintani N, Tanida M, Hayata A, Hashimoto R, Baba A. 2011. PACAP is implicated in the stress axes. Curr. Pharm. Des. 17:985-89
63. Hirashima N, Tsunematsu T, Ichiki K, Tanaka H, Kilduff TS, Yamanaka A. 2011. Neuropeptide B induces slow wave sleep in mice. Sleep 34:1-37
64. Hobson SA, Bacon A, Elliot-Hunt CR, Holmes FE, Kerr NC, et al. 2008. Galanin acts as a trophic factor to the central and peripheral nervous systems. Cell. Mol. Life Sci. 65:1806-12
65. Hokfelt T, Broberger C, Xu ZQ, Sergeyev V, Ubink R, Diez M. 2000. Neuropeptides-an overview. Neuropharmacology 39:1337-56
66. Hook V, FunkelsteinL,LuD, Bark S,Wegrzyn J, Hwang SR. 2008. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu. Rev. Pharmacol. Toxicol. 48:393-423
67. Hu WP, Li JD, Colwell CS, Zhou QY. 2011. Decreased REM sleep and altered circadian sleep regulation in mice lacking vasoactive intestinal polypeptide. Sleep 34:49-56
68. Huang ZL, Urade Y, Hayaishi O. 2007. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol. 7:33-38
69. Jego S, Glasgow SD, Herrera CG, EkstrandM, Reed SJ, et al. 2013. Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus. Nat. Neurosci. 16:1637-43
70. Jewett KA, Krueger JM. 2012. Humoral sleep regulation; interleukin-1 and tumor necrosis factor. Vitam. Horm. 89:241-57
71. Kageyama H, Takenoya F, Shiba K, Shioda S. 2010. Neuronal circuits involving ghrelin in the hypothalamusmediated regulation of feeding. Neuropeptides 44:133-38
72. Kalsbeek A, Yi CX, la Fleur SE, Buijs RM, Fliers E. 2010. Suprachiasmatic nucleus and autonomic nervous system influences on awakening from sleep. Int. Rev. Neurobiol. 93:91-107
73. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, et al. 2009. Amyloid-βdynamics are regulated by orexin and the sleep-wake cycle. Science 326:1005-7
74. Kapas L, Bohnet SG, Traynor TR, Majde JA, Szentirmai E, et al. 2008. Spontaneous and influenza virusinduced sleep are altered in TNF-αdouble- receptor deficient mice. J. Appl. Physiol. 105:1187-98
75. Kastenberger I, Lutsch C,HerzogH, Schwarzer C. 2012. Influence of sex and genetic background on anxietyrelated and stress-induced behaviour of prodynorphin-deficient mice. PLoS ONE 7:e34251
76. Keating GL, Kuhar MJ, Bliwise DL, Rye DB. 2010. Wake promoting effects of cocaine and amphetamineregulated transcript (CART). Neuropeptides 44:241-46
77. Khachaturian H, Watson SJ, Lewis ME,Coy D, Goldstein A, AkilH. 1982. Dynorphin immunocytochemistry in the rat central nervous system. Peptides 3:941-54
78. Kimura M, Muller-Preuss P,Lu A,Wiesner E, FlachskammC, et al. 2010. Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. Mol. Psychiatry 15:154-65
79. Kishi T, Aschkenasi CJ, Choi BJ, Lopez ME, Lee CE, et al. 2005. Neuropeptide Y Y1 receptor mRNA in rodent brain: distribution and colocalization with melanocortin-4 receptor. J. Comp. Neurol. 482:217-43
80. Kojima M, Kangawa K. 2010. Ghrelin: more than endogenous growth hormone secretagogue. Ann. N. Y. Acad. Sci. 1200:140-48
81. Konadhode RR, Pelluru D, Blanco-Centurion C, Zayachkivsky A, LiuM, et al. 2013. Optogenetic stimulation of MCH neurons increases sleep. J. Neurosci. 33:10257-63
82. Koylu EO, Couceyro PR, Lambert PD, Kuhar MJ. 1998. Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain. J. Comp. Neurol. 391:115-32
83. Koylu EO, Couceyro PR, Lambert PD, Ling NC, DeSouza EB, Kuhar MJ. 1997. Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland. J. Neuroendocrinol. 9:823-33
84. Kramer A, Yang FC, Snodgrass P, Li X, Scammell TE, et al. 2001. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 294:2511-15
85. Krueger JM. 2008. The role of cytokines in sleep regulation. Curr. Pharm. Des. 14:3408-16
86. Krueger JM, Rector DM, Roy S, Van Dongen HPA, Belenky G, Panksepp J. 2008. Sleep as a fundamental property of neuronal assemblies. Nat. Rev. Neurosci. 9:910-19
87. Kryger MH, Roth T, DementWC, Siegel JM, eds. 2011. Principles and Practice of Sleep Medicine. Philadelphia, PA: Saunders/Elsevier. 5th ed.
88. Kushikata T, Fang J, Chen Z, Wang Y, Krueger JM. 1998. Epidermal growth factor enhances spontaneous sleep in rabbits. Am. J. Physiol. 275:R509-14
89. Laposky AD, Shelton J, Bass J, Dugovic C, Perrino N, Turek FW. 2006. Altered sleep regulation in leptindeficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290:R894-903
90. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168-76
91. Leinninger GM. 2011. Lateral thinking about leptin: a review of leptin action via the lateral hypothalamus. Physiol. Behav. 104:572-81
92. Lester HA, Mager S, Quick MW, Corey JL. 1994. Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol. 34:219-49
93. Li H, Ohta H, Izumi H,Matsuda Y, Seki M, et al. 2013. Behavioral and cortical EEG evaluations confirm the roles of both CCKA and CCKB receptors in mouse CCK-induced anxiety. Behav. Brain Res. 237:325-32
94. Li Y, van den Pol AN. 2006. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J. Neurosci. 26:13037-47
95. Liao F, Taishi P, Churchill L, Urza MJ,Krueger JM. 2010. Localized suppression of cortical growth hormonereleasing hormone receptors state-specifically attenuates electroencephalographic delta waves. J. Neurosci. 30:4151-59
96. Lin JS, Anaclet C, Sergeeva OA, Haas HL. 2011. The waking brain: an update. Cell. Mol. Life Sci. 68:2499-512
97. Ludwig M, Leng G. 2006. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 7:126-36
98. Majde JA, Krueger JM. 2005. Links between the innate immune system and sleep. J. Allergy Clin. Immunol. 116:1188-98
99. Marder E. 2012. Neuromodulation of neuronal circuits: back to the future. Neuron 76:1-11
100. Martel G, Dutar P, Epelbaum J, Viollet C. 2012. Somatostatinergic systems: an update on brain functions in normal and pathological aging. Front. Endocrinol. 3:154
101. Martinez GS, Smale L, Nunez AA. 2002. Diurnal and nocturnal rodents show rhythms in orexinergic neurons. Brain Res. 955:1-7
102. Masuo Y, Noguchi J, Morita S, Matsumoto Y. 1995. Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines. Brain Res. 700:219-26
103. McCarley RW. 2011. Neurobiology of REM sleep. Handb. Clin. Neurol. 98:151-71
104. McCoyMK, Tansey MG. 2008. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflamm. 5:45
105. Mennicken F, HoffertC, Pelletier M, Ahmad S,ODonnell D. 2002. Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J. Chem. Neuroanat. 24:257-68
106. Moffett M, Stanek L, Harley J, Rogge G, Asnicar M, et al. 2006. Studies of cocaine- and amphetamineregulated transcript (CART) knockout mice. Peptides 27:2037-45
107. Monti JM, Torterolo P, Lagos P. 2013. Melanin-concentrating hormone control of sleep-wake behavior. Sleep Med. Rev. 17:293-98
108. MrosovskyN, Redlin U, Roberts RB, Threadgill DW. 2005. Masking in waved-2 mice: EGF receptor control of locomotion questioned. Chronobiol. Int. 22:963-74
109. Mulder AH, Wardeh G, Hogenboom F, Frankhuyzen AL. 1984. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278-80
110. Murck H, Held K, Ziegenbein M, Kunzel H, Holsboer F, Steiger A. 2004. Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29:1205-11
111. Nelson MD, Raizen DM. 2013. A sleep state during C. elegans development. Curr. Opin. Neurobiol. 23:824-30
112. Nelson MD, Trojanowski NF, George-Raizen JB, Smith CJ, Yu CC, et al. 2013. The neuropeptide NLP-22 regulates a sleep-like state in Caenorhabditis elegans. Nat. Commun. 4:2846
113. OMalley MW, Fishman RL, Ciraulo DA, Datta S. 2013. Effect of five-consecutive-day exposure to an anxiogenic stressor on sleep-wake activity in rats. Front. Neurol. 4:15
114. Obal F Jr, Alt J, Taishi P, Gardi J, Krueger JM. 2003. Sleep in mice with nonfunctional growth hormonereleasing hormone receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284:R131-39
115. Obal F Jr, Krueger JM. 2003. Biochemical regulation of non-rapid-eye-movement sleep. Front. Biosci. 8:d520- 50
116. ODonnell D, Ahmad S, Wahlestedt C, Walker P. 1999. Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J. Comp. Neurol. 409:469-81
117. Oishi Y,Williams RH, Agostinelli L, Arrigoni E, Fuller PM, et al. 2013. Role of the medial prefrontal cortex in cataplexy. J. Neurosci. 33:9743-51
118. Otto C, Martin M, Wolfer DP, Lipp HP, Maldonado R, Sch utz G. 2001. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res. Mol. Brain Res. 92:78-84
119. PattersonCM,LeshanRL, Jones JC, MyersMGJ. 2011. Molecular mapping of mouse brain regions innervated by leptin receptor-expressing cells. Brain Res. 1378:18-28
120. Paut-Pagano L, Roky R, Valatx JL, Kitahama K, Jouvet M. 1993. Anatomical distribution of prolactin-like immunoreactivity in the rat brain. Neuroendocrinology 58:682-95
121. Peterfi Z, McGinty D, Sarai E, Szymusiak R. 2010. Growth hormone-releasing hormone activates sleep regulatory neurons of the rat preoptic hypothalamus.Am. J. Physiol. Regul. Integr.Comp. Physiol. 298:R147- 56
122. Peterfi Z, Obal F Jr, Taishi P, Gardi J, Kacsoh B, et al. 2006. Sleep in spontaneous dwarf rats. Brain Res. 1108:133-46
123. Pieribone VA, Xu ZQ, Zhang X, Grillner S, Bartfai T, Hokfelt T. 1995. Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neuroscience 64:861-74
124. Prober DA, Rihel J, Onah AA, Sung RJ, Schier AF. 2006. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J. Neurosci. 26:13400-10
125. Rihel J, Prober DA, Arvanites A, Lam K, Zimmerman S, et al. 2010. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327:348-51
126. Rihel J, Schier AF. 2013. Sites of action of sleep and wake drugs: insights from model organisms. Curr. Opin. Neurobiol. 23:831-40
127. Rios M, Fan G, Fekete C, Kelly J, Bates B, et al. 2001. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15:1748-57
128. Riou F, Cespuglio R, Jouvet M. 1982. Endogenous peptides and sleep in the rat: III. The hypnogenic properties of vasoactive intestinal polypeptide. Neuropeptides 2:265-77
129. Rizzi A, Molinari S, Marti M, Marzola G, Calo G. 2011. Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. Neuropharmacology 60:572-79
130. Romanowski CP, Fenzl T, Flachskamm C, Wurst W, Holsboer F, et al. 2010. Central deficiency of corticotropin-releasing hormone receptor type 1 (CRH-R1) abolishes effects of CRH on NREM but not on REM sleep in mice. Sleep 33:427-36
131. Sakurai T. 2007. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci. 8:171-81
132. Sakurai T, Mieda M. 2011. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol. Sci. 32:451-62
133. Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. 2010. Sleep state switching. Neuron 68:1023-42
134. SaperCB, Lu J, Chou TC,Gooley J. 2005. The hypothalamic integrator for circadian rhythms. Trends Neurosci. 28:152-57
135. Sauvage M, Steckler T. 2001. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neuroscience 104:643-52
136. Schier AF. 2013. Should I stay or should I go: neuromodulators of behavioral states. Cell 154:955-56
137. Schone C, BurdakovD. 2012. Glutamate and GABA as rapid effectors of hypothalamic peptidergic neurons. Front. Behav. Neurosci. 6:81
138. Scott MM, Lachey JL, Sternson SM, Lee CE, Elias CF, et al. 2009. Leptin targets in the mouse brain. J. Comp. Neurol. 514:518-32
139. Sehgal A, Mignot E. 2011. Genetics of sleep and sleep disorders. Cell 146:194-207
140. Sei M, Sei H, Shima K. 1999. Spontaneous activity, sleep, and body temperature in rats lacking the CCK-A receptor. Physiol. Behav. 68:25-29
141. Seutin V, Verbanck P, Massotte L, Dresse A. 1989. Galanin decreases the activity of locus coeruleus neurons in vitro. Eur. J. Pharmacol. 164:373-76
142. Shaw PJ, Cirelli C, Greenspan RJ, Tononi G. 2000. Correlates of sleep and waking in Drosophila melanogaster. Science 287:1834-37
143. Shemyakin A, Kapas L. 2001. L-364,718, a cholecystokinin-A receptor antagonist, suppresses feeding-induced sleep in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280:R1420-26
144. Sherin JE, Elmquist JK,Torrealba F, Saper CB. 1998. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci. 18:4705-21
145. Siaud P, Manzoni O, Balmefrezol M, Barbanel G, Assenmacher I, Alonso G. 1989. The organization of prolactin-like-immunoreactive neurons in the rat central nervous system. Light- and electronmicroscopic immunocytochemical studies. Cell Tissue Res. 255:107-15
146. Siegel JM. 2005. Clues to the functions of mammalian sleep. Nature 437:1264-71
147. Siegel JM. 2009. Sleep viewed as a state of adaptive inactivity. Nat. Rev. Neurosci. 10:747-53
148. Siegel JM. 2011. Sleep in animals: a state of adaptive inactivity. See Kryger et al. 2011, pp. 126-38
149. Signore AP, Zhang F,Weng Z, Gao Y, Chen J. 2008. Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials. J. Neurochem. 106:1977-90
150. Sinton CM, Fitch TE, Gershenfeld HK. 1999. The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation. J. Sleep Res. 8:197-203
151. Smith PM, Ferguson AV. 2008. Neurophysiology of hunger and satiety. Dev. Disabil. Res. Rev. 14:96-104
152. Snodgrass-Belt P, Gilbert JL, Davis FC. 2005. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters. Brain Res. 1038:171-82
153. Steiger A. 2007. Neurochemical regulation of sleep. J. Psychiatr. Res. 41:537-52
154. Sternson SM. 2013. Hypothalamic survival circuits: blueprints for purposive behaviors. Neuron 77:810-24
155. Szentirmai E. 2012. Central but not systemic administration of ghrelin induces wakefulness in mice. PLoS ONE 7:e41172
156. Szentirmai E, Kapas L, Sun Y, Smith RG, Krueger JM. 2007. Spontaneous sleep and homeostatic sleep regulation in ghrelin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R510-17
157. Szentirmai E, Krueger JM. 2006. Obestatin alters sleep in rats. Neurosci. Lett. 404:222-26
158. Tafti M. 2007. Quantitative genetics of sleep in inbred mice. Dialogues Clin. Neurosci. 9:273-78
159. Tobler I. 2011. Phylogeny of sleep regulation. See Kryger et al. 2011, pp. 76-91
160. Tononi G, Cirelli C. 2012. Time to be SHY? Some comments on sleep and synaptic homeostasis. Neural Plast. 2012:415250
161. Torterolo P, Lagos P, Monti JM. 2011. Melanin-concentrating hormone: a new sleep factor? Front. Neurol. 2:14
162. Tsujino N, Sakurai T. 2013. Role of orexin in modulating arousal, feeding, and motivation. Front. Behav. Neurosci. 7:28
163. Tsujino N, Yamanaka A, Ichiki K, Muraki Y, Kilduff TS, et al. 2005. Cholecystokinin activates orexin/ hypocretin neurons through the cholecystokinin A receptor. J. Neurosci. 25:7459-69
164. Urade Y, Hayaishi O. 2011. Prostaglandin D2 and sleep/wake regulation. Sleep Med. Rev. 15:411-18
165. van den Pol AN. 2012. Neuropeptide transmission in brain circuits. Neuron 76:98-115
166. Varela L,Horvath TL. 2012. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep. 13:1079-86
167. VaudryD, Falluel-Morel A, Bourgault S, Basille M, BurelD, et al. 2009. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 61:283-357
168. Venner A,KarnaniMM,Gonzalez JA, Jensen LT, Fugger L, BurdakovD. 2011. Orexin neurons as conditional glucosensors: paradoxical regulation of sugar sensing by intracellular fuels. J. Physiol. 589:5701-8
169. WangQ, ShinEJ, Nguyen XK,LiQ,Bach JH, et al. 2012. Endogenous dynorphin protects against neurotoxinelicited nigrostriatal dopaminergic neuron damage and motor deficits in mice. J. Neuroinflamm. 9: 124
170. Welsh DK, Takahashi JS, Kay SA. 2010. Suprachiasmatic nucleus: cell autonomy and network properties. Annu. Rev. Physiol. 72:551-77
171. Williams KS, Behn CG. 2011. Dynamic interactions between orexin and dynorphin may delay onset of functional orexin effects: a modeling study. J. Biol. Rhythms 26:171-81
172. Willie JT, Sinton CM, Maratos-Flier E, Yanagisawa M. 2008. Abnormal response of melanin-concentrating hormone deficient mice to fasting: hyperactivity and rapid eye movement sleep suppression. Neuroscience 156:819-29
173. Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, et al. 2004. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24:11439-48
174. Woods IG, SchoppikD, Shi V, Zimmerman S, ColemanHA, et al. 2014. Neuropeptidergic signaling partitions arousal behaviors in zebrafish. J. Neurosci. 34:3142-60
175. Xie X,Wisor JP, Hara J, Crowder TL, LeWinter R, et al. 2008. Hypocretin/orexin and nociceptin/orphanin FQcoordinately regulate analgesia in amousemodel of stress-induced analgesia. J. Clin. Invest. 118:2471-81
176. Yamanaka A, BeuckmannCT, Willie JT,Hara J,Tsujino N, et al. 2003. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38:701-13
177. Zager A, AndersenML, Ruiz FS, Antunes IB, Tufik S. 2007. Effects of acute and chronic sleep loss on immune modulation of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293:R504-9
178. Zeitzer JM. 2013. Control of sleep andwakefulness in health and disease. Prog.Mol. Biol. Transl. Sci. 119:137-54
179. Zhang G, Wang L, Liu H, Zhang J. 2004. Substance P promotes sleep in the ventrolateral preoptic area of rats. Brain Res. 1028:225-32
180. Zielinski MR, Krueger JM. 2011. Sleep and innate immunity. Front. Biosci. 3:632-42
181. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. 2006. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J. Comp. Neurol. 494:528-48